Direct in vivo evidence of activated macrophages in human osteoarthritis  by Byers Kraus, V. et al.
RISK FOR INCIDENT OA BY EFFUSION SYNOVITIS AND HOFFA SYNOVITIS
Overall N (%) Cases N (%) Controls N (%) Hazard ratio (95% CI)
BASELINE FOR EFFUSION-SYNOVITIS (N¼126) Effusion-synovitis present 17 (13.5) 13 (20.6) 4 (6.4) 5.5 (1.2–24.8)
Effusion-synovitis Absent 109 (86.5) 50 (79.4) 59 (93.7)
BASELINE FOR HOFFA SYNOVITIS (N¼125) Hoffa synovitis present 39 (31.2) 24 (38.7) 15 (23.8) 2 (0.9–4.5)
Hoffa synovitis absent 86 (68.8) 38 (61.3) 48 (76.2)
P1 FOR EFFUSION-SYNOVITIS (N¼118) Effusion-synovitis present 28 (23.7) 24(40.7) 4 (6.8) 7.7 (2.3–25.5)
Effusion-synovitis Absent 90 (76.3) 35 (59.3) 55 (93.2)
P1 FOR HOFFA SYNOVITIS (N¼117) Hoffa synovitis present 42 (35.9) 27 (46.6) 15 (25.4) 3 (1.2–7.6)
Hoffa synovitis absent 75 (64.1) 31 (53.5) 44 (25.4)
P0 FOR EFFUSION- SYNOVITIS (N¼118) Effusion-synovitis present 45 (38.1) 36 (61.0) 9 (15.3) 28 (3.8–205.8)
Effusion-synovitis Absent 73 (61.9) 23 (39.0) 50 (84.8)
P0 FOR HOFFA SYNOVITIS (N¼116) Hoffa synovitis present 43 (37.1) 29 (50) 14 (24.1) 4 (1.5–10.7)
Hoffa synovitis absent 73 (62.9) 29(50) 44 (75.9)
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DIRECT IN VIVO EVIDENCE OF ACTIVATED MACROPHAGES IN
HUMAN OSTEOARTHRITIS
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Indianapolis, IN, USATable-Association of 99mTc-EC20 uptake indicative of activated macrophages
with severity of knee OA.
JSN OST Symptoms
Site of
Macrophages
parameter
estimate
(p value)
parameter
estimate
(p value)
parameter
estimate
(p value)
Synovium 0.157 (0.006) 0.756 (0.011) 0.231 (<0.0001)
Joint Capsule 0.234 (0.007) 0.988 (0.001) 0.231 (0.004)Purpose: Although it is well accepted that activated synovial macro-
phages play a key role in Rheumatoid Arthritis, the role of inﬂammation
in Osteoarthritis (OA) is controversial. The purpose of this study was to
investigate the involvement of activated macrophages in OA through
a new imaging modality called FolateScan imaging.
Methods: FolateScan (Endocyte, West Lafayette, Indiana) is a scinti-
graphic imaging technique that provides a method of detecting acti-
vated but not resting monocytes or macrophages. The radioligand for
this imaging technology, Etarfolatide (or EC20), consists of a targeting
moiety (folic acid) linked to a chelating moiety enabling coupling to
technetium-99m (99mTc). Targeting to activated macrophages is ach-
ieved through binding of folate receptor b on the surface of activated
macrophages. A total of 25 participants (both knees studied) with
symptomatic radiographic knee OA of at least one knee were recruited
for the study. Single photon emission computed tomography with
computed tomography coregistration (SPECT/CT) of each knee was
performed to precisely localize radioligand uptake with regard to
anatomical structures of the knee; the intensity of uptakewas scored by
an experienced reader (REC) on a 0-3 scale for the synovium, joint
capsule, and subchondral bone in all three compartments of the knee.
Whole body scintigraphy was also performed to identify other sites of
99mTc-EC20 uptake for correlation with joint symptoms. We evaluated
the associations of intensity of 99mTc-EC20 uptake with radiographic
OA severity including joint space narrowing (JSN) and osteophyte (OST)
scoredwith the aid of a standard radiographic atlas, and severity of joint
symptoms (pain, aching, stiffness); we ﬁt models using generalized
estimating equations with control for age, gender and body mass index
(BMI). P values <0.05 were considered signiﬁcant.
Results: The cohort was 72% female, 92% Caucasian, mean (SD) age
62.4+15.8 years (range 30-89), and mean (SD) body mass index (BMI)
29.2+4.8 (range 22.5-38.4) kg/m2. By Kellgren Lawrence grading, all
knees showed some evidence of radiographic OA spanning the full
range of severities with KL1 (24%), KL2 (26%), KL3 (32%), KL4 (18%).
Intra-rater reliability of FolateScan scoring was high (k statistic range
0.68-0.90). There was only one adverse event during the study; one
participant reported temporary mild dysgeusia. The presence of acti-
vatedmacrophages was detected in the majority (66%) of knees (n¼50);
28% of knees had activated macrophages in more than one knee
compartment. Synovial and joint capsular macrophages were both
strongly associated with joint space narrowing, osteophyte severity,
and knee symptoms (see Table-parameter estimates and p values
adjusted for age, gender and BMI). Additional joints commonly affected
by OA, such as the shoulders, carpometacarpal joints, and meta-
tarsophalangeal joints were frequently also inﬁltrated with activated
macrophages (26%, 28%, and 14% of scans positive, respectively);
99mTc-EC20 uptake at the ankles and ﬁrst metatarsophalangeal joints
was strongly associated with joint pain at these sites.Conclusions: This study provides the ﬁrst direct in vivo evidence for
macrophage involvement in OA and demonstrates the ability of the
FolateScan technology to differentiate inﬂammatory and non-inﬂam-
matory activity states of OA patients. These results suggest that drugs
targeting macrophages and macrophage associated inﬂammatory
pathways may decrease OA symptoms and progression of joint struc-
tural deterioration.
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TRANSCRIPTOMICS ON SYNOVIAL SPECIMEN OF EARLY HUMAN
(CHECK) AND EXPERIMENTAL OA TO IDENTIFY PATHWAYS AND
PROCESSES ASSOCIATED WITH CARTILAGE DAMAGE
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Purpose: The majority of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. How synovitis
contributes to the irreversible joint pathology is not known. In the
present study we usedmicroarray analysis of synovial tissue of early OA
patients and of experimental OA, to identify common pathways that
determine cartilage damage in this disease.
Methods: Longitudinal expression analysis was performed on murine
synovial tissue at day 7, day 21 and day 42 in collagenase induced OA
(CIOA) and the surgically induced DMM model (destabilization of the
medial meniscus). CIOA was induced by intra-articular injection of
collagenase, which causes joint instability. From a subpopulation of
patients (n¼ 25) that entered the CHECK Cohort study (Cohort Hip and
Cohort Knee) and 7 controls, synovial biopsies were collected at year 0,
2 and 5. CHECK is a prospective 10-year follow-up study on participants
with early osteoarthritis-related complaints initiated by the Dutch
Arthritis Association. Kellgren&Lawrence-score (KL) at inclusion was
determined (n¼18) and follow up measurements were performed at 2
and 5 years. Affymetrix was used for microarray, and pathway analysis
was done using DAVID.
